R&D
Research Performance.
Humasis has been proving better research results based on its innovative technologies.
2023
- Development HIV raw materials for immunodiagnostic kit
- Development Humasis COVID -19/Flu Ag Combo test (Ministry of Food and Drug Safety Authorization)
2022
- Developed 2022 COVID-19 NP Antigen
- Humasis COVID -19 Ag N Test (permitted for export)
- Humasis hs -Malaria P.f/Pan Antigen Test (permitted for export)
- Developed Humasis COVID-19 RT-PCR Kit (certified by Ministry of Food and Drug Safety, CE)
- Developed Humasis COVID-19 Variant RT-qPCR Kit (permitted by Ministry of Food and Drug Safety for export)
- Developed Ministry of Food and Drug Safety (RUO)
2021
- Wellness R&D, Developed monitoring system
2020
- Developed HUBI-TAS (permitted by CE, Ministry of Food and Drug Safety)
- Developed Novel Coronavirus (COVID-19) antigen test
2019
- Developed AI engine
2018
- Influenza/RSV Test Kit
- High-Sensitivity HIV Antigen Test Kit
2017
- High-Sensitivity HCV Antigen Test Kit
- Developed Quantitative Reagent for LH and FSH
- Developed PCT Quantitative Test Reagent
2016
- High-Sensitivity Pregnancy Test Kit